T2 Biosystems (NASDAQ:TTOO) Now Covered by StockNews.com

StockNews.com started coverage on shares of T2 Biosystems (NASDAQ:TTOO) in a research report sent to investors on Friday. The brokerage issued a sell rating on the medical equipment provider’s stock.

T2 Biosystems Stock Down 6.3 %

Shares of TTOO stock opened at $0.06 on Friday. The company has a 50-day simple moving average of $0.31 and a 200 day simple moving average of $1.47. T2 Biosystems has a 52 week low of $0.06 and a 52 week high of $6.95.

T2 Biosystems Company Profile

T2 Biosystems, Inc, an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine.